This study investigates advanced or refractory solid tumors. The purpose of this study is to understand more about these types of cancers.
The focus of this study is to evaluate the safety of an investigational medication. Researchers will learn about how well people tolerate it.
- Who can participate: Participants must be 18 years or older with advanced solid tumors that have progressed after standard treatments. They should be in good physical condition with no other active cancers for at least 2 years.
- Study details: Participants will receive an investigational medication through an intravenous infusion.